Description
Monovisc is a single, intraarticular injection of cross-linked sodium hyaluronate designed to treat the symptoms of osteoarthritis. Monovisc is indicated as a viscosupplement or as a replacement for synovial fluid in human joints. It is well suited for treatment of the symptoms of human joint dysfunctions, such as osteoarthritis.